Ali Afnan on Real Time Release and End of Line Testing

At the 2009 Emerson Users Exchange, Ali Afnan, senior Fellow at FDA's Center for Drug Evaluation and Research, discusses real time release, highlighting Aventis work with API and finished drug manufacturing. End-of-line testing isn't bad, he says, but it needs to be used for different reasons.